Attached files

file filename
EX-32.2 - EXHIBIT 32-2 - Emmaus Life Sciences, Inc.s104819_ex32-2.htm
EX-32.1 - EXHIBIT 32-1 - Emmaus Life Sciences, Inc.s104819_ex32-1.htm
EX-31.2 - EXHIBIT 31-2 - Emmaus Life Sciences, Inc.s104819_ex31-2.htm
EX-31.1 - EXHIBIT 31-1 - Emmaus Life Sciences, Inc.s104819_ex31-1.htm
EX-21.1 - EXHIBIT 21-1 - Emmaus Life Sciences, Inc.s104819_ex21-1.htm
EX-10.24 - EXHIBIT 10-24 - Emmaus Life Sciences, Inc.s104819_ex10-24.htm
EX-10.23 - EXHIBIT 10-23 - Emmaus Life Sciences, Inc.s104819_ex10-23.htm
EX-4.6 - EXHIBIT 4-6 - Emmaus Life Sciences, Inc.s104819_ex4-6.htm
EX-4.5 - EXHIBIT 4-5 - Emmaus Life Sciences, Inc.s104819_ex4-5.htm
EX-4.4 - EXHIBIT 4-4 - Emmaus Life Sciences, Inc.s104819_ex4-4.htm
EX-3.1 - EXHIBIT 3-1 - Emmaus Life Sciences, Inc.s104819_ex3-1.htm
10-K - 10-K - Emmaus Life Sciences, Inc.s104819_10k.htm

 

Exhibit 23.1

 

 

Consent of Independent Registered Public Accounting Firm

 

To the Board of Directors and Stockholders

of MYnd Analytics, Inc.

26522 La Alameda, Suite 290

Mission Viejo, CA 92691

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-166394) of MYnd Analytics, Inc. of our report dated December 22, 2016, relating to the consolidated financial statements which appear in this Form 10-K.

 

  /s/ Anton & Chia, LLP
  Newport Beach, California
  December 22, 2016